USA - NYSEARCA:CMD -
ChartMill assigns a Buy % Consensus number of 65% to CMD. The Buy consensus is the weighted average rating of the current analysts ratings.
4 analysts have analysed CMD and the average price target is 63.24 null. This implies a price decrease of -21.31% is expected in the next year compared to the current price of 80.37.
The consensus rating for Cantel Medical (CMD) is 65 / 100 . This indicates that analysts generally have a neutral outlook on the stock.